Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 346

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 346
---
 the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company is a single segment entity. When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

| ​                                          | ​ 
 ​ | ​ |                 ​ 
 December 31, 2024 | ​ | ​ |                 ​ 
 December 31, 2023 |
|:-------------------------------------------|:--|:--|------------------:|:--|:--|------------------:|
| Cash                                       | ​ | $ |            65,343 | ​ | $ |           156,425 |
| Cash and Investments held in Trust Account | ​ | $ |         2,016,274 | ​ | $ |         4,291,332 |

| ​                                                                  
 ​                                                                  | ​ 
 ​ 
 ​ | ​                  
 For the Year Ended |                 ​ 
 December 31, 2024 | ​ 
 ​ | ​                  
 For the Year Ended |                 ​ 
 December 31, 2023 |
|:-------------------------------------------------------------------|:--|:-------------------|------------------:|:--|:-------------------|------------------:|
| Other general and administrative expenses                          | ​ | $                  |         1,909,768 | ​ | $                  |         1,231,012 |
| Professional services fees in connection with Business Combination | ​ | ​                  |           996,551 | ​ | ​                  |         1,071,934 |
| Total operating expenses                                           | ​ | $                  |         2,906,319 | ​ | $                  |         2,302,946 |
| ​                                                                  | ​ | ​                  |                 ​ | ​ | ​                  |                 ​ |
| Interest income on investments held in Trust Account               | ​ | $                  |           137,717 | ​ | $                  |           553,641 |

The key measures of segment profit or loss reviewed by the CODM are interest earned on investments held in Trust Account and operating and formation costs. The CODM reviews interest earned on investments held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. Within the operating expenses, the CODM specifically reviews professional service fees in connection with the Business Combination, which are a significant segment expense, and include legal fees, and advisory